Multiple Myeloma
FDA approves Velcade treatment
Published in Medical Letter on the CDC and FDA, June 8th, 2003
FDA reviewed the application for this drug in less than 4 months. Velcade is the first in a new class of anticancer agents known as proteasome inhibitors.
Velcade was approved under the accelerated approval program. The program helps make promising products for serious or life-threatening diseases available earlier in the development process by allowing approval to be based on a promising effect of the drug, such as tumor shrinkage, before there is actual evidence of improved survival or other clinical...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Letter on the CDC and FDA
More Articles from Medical Letter on the CDC and FDA
- HIV/AIDS Therapy
Fatigue in HIV-positive patients often has treatable causes - SARS
CDC says limits on meetings with international visitors unnecessary - Bubonic Plague
Yersinia pestis survives for days on environmental surfaces - Drug Resistance
Antimicrobial drug prescriptions on the rise in ambulatory care settings - Environmental Health
Apple storage and washing treatments affect patulin levels in apple cider - Zoonosis
SIV from multiple lineages can infect human macrophages - More from this issue of Medical Letter on the CDC and FDA
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
